Piperlongumine inhibits proliferation and survival of Burkitt lymphoma in vitro

Leukemia Research

Volumn 37, Issue 2, 2013, Pages 146-154

  Han, Seong Su ^a   Son, Dong Ju ^b   Yun, Hwakyung ^c   Kamberos, Natalie L ^a   Janz, Siegfried ^a  

^a UNIVERSITY OF IOWA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Hanseo University   (South Korea)

Author keywords

B cell malignancy; Cancer therapy and prevention; Long pepper; Non Hodgkin lymphoma; Pyridone alkaloid

Indexed keywords

ALKALOID; ANTINEOPLASTIC AGENT; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; PIPERLONGUMINE; PROTEIN MYB; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BURKITT LYMPHOMA; CELL GROWTH; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG STRUCTURE; E2F1 GENE; GADD45B GENE; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VIVO STUDY; LMP 1 GENE; LYMPHOMA CELL; MYB GENE; PERIPHERAL LYMPHOCYTE; PHYTOCHEMISTRY; PIPER LONGUM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION;

ANTIGENS, DIFFERENTIATION; ANTINEOPLASTIC AGENTS; APOPTOSIS; BURKITT LYMPHOMA; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DIOXOLANES; E2F1 TRANSCRIPTION FACTOR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYB; HUMANS; INHIBITORY CONCENTRATION 50; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-MYC; VIRAL MATRIX PROTEINS;

EID: 84872374148     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.11.009     Document Type: Article

References (47)

1. Gullett N.P., Ruhul Amin A.R., Bayraktar S., Pezzuto J.M., Shin D.M., Khuri F.R., et al. Cancer prevention with natural compounds. Semin Oncol 2010, 37:258-281.
2. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003, 3:768-780.
3. Kumar S., Kamboj J., Suman, Sharma S. Overview for various aspects of the health benefits of Piper longum Linn. fruit. J Acupunct Meridian Stud 2011, 4:134-140.
4. Natarajan K.S., Narasimhan M., Shanmugasundaram K.R., Shanmugasundaram E.R. Antioxidant activity of a salt-spice-herbal mixture against free radical induction. J Ethnopharmacol 2006, 105:76-83.
5. Kumar S., Arya P., Mukherjee C., Singh B.K., Singh N., Parmar V.S., et al. Novel aromatic ester from Piper longum and its analogues inhibit expression of cell adhesion molecules on endothelial cells. Biochemistry 2005, 44:15944-15952.
6. Park B.S., Son D.J., Choi W.S., Takeoka G.R., Han S.O., Kim T.W., et al. Antiplatelet activities of newly synthesized derivatives of piperlongumine. Phytother Res 2008, 22:1195-1199.
7. Jin Z., Borjihan G., Zhao R., Sun Z., Hammond G.B., Uryu T. Antihyperlipidemic compounds from the fruit of Piper longum L. Phytother Res 2009, 23:1194-1196.
8. Qi H.S., Liu P., Gao S.Q., Diao Z.Y., Yang L.L., Xu J., et al. Inhibitory effect of piperlonguminine/dihydropiperlonguminine on the production of amyloid beta and APP in SK-N-SH cells. Chin J Physiol 2009, 52:160-168.
9. Rodrigues R.V., Lanznaster D., Longhi Balbinot D.T., Gadotti Vde M., Facundo V.A., Santos A.R. Antinociceptive effect of crude extract, fractions and three alkaloids obtained from fruits of Piper tuberculatum. Biol Pharm Bull 2009, 32:1809-1812.
10. Ghoshal S., Lakshmi V. Potential antiamoebic property of the roots of Piper longum Linn. Phytother Res 2002, 16:689-691.
11. Moraes J., Nascimento C., Lopes P.O., Nakano E., Yamaguchi L.F., Kato M.J., et al. Schistosoma mansoni: in vitro schistosomicidal activity of piplartine. Exp Parasitol 2011, 127:357-364.
12. Naz T., Mosaddik A., Rahman M.M., Muhammad I., Haque M.E., Cho S.K. Antimicrobial, antileishmanial and cytotoxic compounds from Piper chaba. Nat Prod Res 2011.
13. Chaithong U., Choochote W., Kamsuk K., Jitpakdi A., Tippawangkosol P., Chaiyasit D., et al. Larvicidal effect of pepper plants on Aedes aegypti (L.) (Diptera: Culicidae). J Vector Ecol 2006, 31:138-144.
14. Choochote W., Chaithong U., Kamsuk K., Rattanachanpichai E., Jitpakdi A., Tippawangkosol P., et al. Adulticidal activity against Stegomyia aegypti (Diptera: Culicidae) of three Piper spp. Rev Inst Med Trop Sao Paulo 2006, 48:33-37.
15. Christina A.J., Saraswathy G.R., Robert S.J., Kothai R., Chidambaranathan N., Nalini G., et al. Inhibition of CCl4-induced liver fibrosis by Piper longum Linn.?. Phytomedicine 2006, 13:196-198.
16. Sunila E.S., Kuttan G. Protective effect of Piper longum fruit ethanolic extract on radiation induced damages in mice: a preliminary study. Fitoterapia 2005, 76:649-655.
17. Kong E.H., Kim Y.J., Cho H.J., Yu S.N., Kim K.Y., Chang J.H., et al. Piplartine induces caspase-mediated apoptosis in PC-3 human prostate cancer cells. Oncol Rep 2008, 20:785-792.
18. Pradeep C.R., Kuttan G. Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice. Clin Exp Metastasis 2002, 19:703-708.
19. Raj L., Ide T., Gurkar A.U., Foley M., Schenone M., Li X., et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011, 475:231-234.
20. Toth C.R., Hostutler R.F., Baldwin A.S., Bender T.P. Members of the nuclear factor kappa B family transactivate the murine c-myb gene. J Biol Chem 1995, 270:7661-7671.
21. Han S.S., Keum Y.S., Chun K.S., Surh Y.J. Suppression of phorbol ester-induced NF-kappaB activation by capsaicin in cultured human promyelocytic leukemia cells. Arch Pharm Res 2002, 25:475-479.
22. Han S.S., Kim K., Hahm E.R., Park C.H., Kimler B.F., Lee S.J., et al. Arsenic trioxide represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60. J Cell Biochem 2005, 94:695-707.
23. Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R.C., Croce C.M. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 1982, 79:7824-7827.
24. Taub R., Kirsch I., Morton C., Lenoir G., Swan D., Tronick S., et al. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA 1982, 79:7837-7841.
25. Han S.S., Peng L., Chung S.T., DuBois W., Maeng S.H., Shaffer A.L., et al. CDDO-imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasms. Mol Cancer 2006, 5:22.
26. Lee H., Arsura M., Wu M., Duyao M., Buckler A.J., Sonenshein G.E. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J Exp Med 1995, 181:1169-1177.
27. Saha A., Robertson E.S. Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes. Clin Cancer Res 2011, 17:3056-3063.
28. Shair K.H., Bendt K.M., Edwards R.H., Bedford E.C., Nielsen J.N., Raab-Traub N. EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas. PLoS Pathogens 2007, 3:e166.
29. Faumont N., Durand-Panteix S., Schlee M., Gromminger S., Schuhmacher M., Holzel M., et al. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells. J Virol 2009, 83:5014-5027.
30. Bezerra D.P., Militao G.C., de Castro F.O., Pessoa C., de Moraes M.O., Silveira E.R., et al. Piplartine induces inhibition of leukemia cell proliferation triggering both apoptosis and necrosis pathways. Toxicol In Vitro 2007, 21:1-8.
31. Bezerra D.P., Vasconcellos M.C., Machado M.S., Villela I.V., Rosa R.M., Moura D.J., et al. Piplartine induces genotoxicity in eukaryotic but not in prokaryotic model systems. Mutat Res 2009, 677:8-13.
32. Bokesch H.R., Gardella R.S., Rabe D.C., Bottaro D.P., Linehan W.M., McMahon J.B., et al. A new hypoxia inducible factor-2 inhibitory pyrrolinone alkaloid from roots and stems of Piper sarmentosum. Chem Pharm Bull (Tokyo) 2011, 59:1178-1179.
33. Lim K.H., Yang Y., Staudt L.M. Pathogenetic importance and therapeutic implications of NF-kappaB in lymphoid malignancies. Immunol Rev 2012, 246:359-378.
34. Singh N., Kumar S., Singh P., Raj H.G., Prasad A.K., Parmar V.S., et al. Piper longum Linn., extract inhibits TNF-alpha-induced expression of cell adhesion molecules by inhibiting NF-kappaB activation and microsomal lipid peroxidation. Phytomedicine 2008, 15:284-291.
35. Han S.S., Keum Y.S., Seo H.J., Chun K.S., Lee S.S., Surh Y.J. Capsaicin suppresses phorbol ester-induced activation of NF-kappaB/Rel and AP-1 transcription factors in mouse epidermis. Cancer Lett 2001, 164:119-126.
36. Han S.S., Keum Y.S., Seo H.J., Surh Y.J. Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 2002, 35:337-342.
37. Han S.S., Yun H., Son D.J., Tompkins V.S., Peng L., Chung S.T., et al. NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma. Mol Cancer 2010, 9:97.
38. Han S.S., Chung S.T., Robertson D.A., Ranjan D., Bondada S. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin Immunol 1999, 93:152-161.
39. Eilers M., Eisenman R.N. Myc's broad reach. Genes Dev 2008, 22:2755-2766.
40. Zheng C., Ren Z., Wang H., Zhang W., Kalvakolanu D.V., Tian Z., et al. E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells. Cancer Res 2009, 69:2324-2331.
41. Engelmann D., Putzer B.M. The dark side of E2F1: in transit beyond apoptosis. Cancer Res 2012, 72:571-575.
42. Zhou H., Du M.Q., Dixit V.M. Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell 2005, 7:425-431.
43. Graham J.P., Arcipowski K.M., Bishop G.A. Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1. Immunol Rev 2010, 237:226-248.
44. De Smaele E., Zazzeroni F., Papa S., Nguyen D.U., Jin R., Jones J., et al. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 2001, 414:308-313.
45. Liebermann D.A., Tront J.S., Sha X., Mukherjee K., Mohamed-Hadley A., Hoffman B. Gadd45 stress sensors in malignancy and leukemia. Crit Rev Oncog 2011, 16:129-140.
46. Cho H.J., Park S.M., Hwang E.M., Baek K.E., Kim I.K., Nam I.K., et al. Gadd45b mediates Fas-induced apoptosis by enhancing the interaction between p38 and retinoblastoma tumor suppressor. J Biol Chem 2010, 285:25500-25505.
47. Bezerra D.P., de Castro F.O., Alves A.P., Pessoa C., de Moraes M.O., Silveira E.R., et al. In vitro and in vivo antitumor effect of 5-FU combined with piplartine and piperine. J Appl Toxicol 2008, 28:156-163.